Table 1.
Biomarkers for severe SARS-CoV-2 infection
Study | Biomarkers | Mechanism of action of the makers |
Levels in patients with COVID- 19 |
Levels in the control group |
p-value | Method of Collection |
---|---|---|---|---|---|---|
Giron et al, 2021 | Zonulin | Zonulin increases the permeability of the intestinal epithelium barrier and blood-brain barrier by modifying tight junctions and the underlying actin cytoskeleton. | 50 ng/ml | 0 ng/ml | 4.96e-7 | Serum blood |
Rossi et al, 2021 | TMPRSS2/ACE2 | TMPRSS2 is found on the intestinal epithelium that plays an important role in the activation and cell entry of SARS-CoV-2 | 0.63 | 0.33 | <0.05 | RT-qPCR from nasopharyngeal swab |
Thomas et al, 2020 | Tryptophan | Tryptophan is involved in the kynurenine pathway to synthesize nicotinamide, which is involved in the mTOR pathway in the intestinal epithelium. This is responsible for transcribing antimicrobial peptides | 2.0 x 10-7 | 4.0 x 10-7 | < 0.001 | Serum blood |
Lee et al, 2020 | IL-17 | IL-17 leads to endothelial dysfunction, intestinal dysbiosis, release of cytotoxic immune cell, and chemokine production in the brain tissue leading to neuroinflammation | 1.225 pg/mL | 0.126 pg/mL | < 0.00001 | Serum blood |